Antiviral Natural Product Combination, in Particular for the Treatment of SARS-CoV-2 Infections

Publication: DE102021115792A1
Published: 2022-02-17
Family Size: 1
Granted: No

Simple SummaryContent extracted from patent full text and abstract with AI.

The invention outlines a safe and simple antiviral composition made from natural substances aimed particularly at combating coronaviruses such as SARS-CoV-2. This formulation combines a bioflavonoid, a salicylate, vitamin D, and optionally ascorbate (vitamin C), calcium, and magnesium to boost antiviral effects.

Use CasesContent extracted from patent full text and abstract with AI.

  • Treatment or supportive therapy for SARS-CoV-2 (COVID-19) infections
  • Treatment or prevention of illnesses caused by other coronaviruses
  • General immune system strengthening for viral infection prevention
  • Development of over-the-counter antiviral supplements
  • Adjunctive use alongside conventional antiviral medications in clinical settings

BenefitsContent extracted from patent full text and abstract with AI.

  • Composed of well-known, safe natural ingredients with established safety profiles
  • May reduce the severity or duration of coronavirus infections
  • Easily produced and administered as a supplement or supportive therapy
  • Likely to have fewer side effects compared to synthetic pharmaceuticals
  • Can be used as a preventive measure during viral outbreaks

Technical Classifications (CPCs)

Main Classifications

Health, Food & Consumer Tech

Sub Classifications

Medical & Vet Science

CPC Codes

A61K31/375A61K31/593A61K31/616A61K31/7048A61K33/08A61K33/10A61P31/14

Inventors & Applicants

Inventors

Applicants

Technische Univ Bergakademie Freiberg Koerperschaft des Oeffentlichen Rechts

Patent Abstract

Die Erfindung betrifft ein einfaches unbedenkliches Mittel mit antiviraler Wirkung gegen Coronaviren speziell SARS-CoV-2. Dazu wird ein Bioflavonoid in Kombination mit einem Salicylat und Vitamin D und ggf. einem Ascorbat, Calcium und Magnesium eingesetzt.

Key Information

Publication No.

DE102021115792A1

Family ID

80000669

Publication Date

2022-02-17

Application No.

DE102021115792A

Application Date

2021-06-18

Priority Date

2021-06-18

Granted

No

Possible Cooperation

For further information please contact the transfer office.